Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
22 October 2010
IN THIS ISSUE
Combating counterfeits
Improving API quality
GSK’s rare diseases unit
FDA discusses PDUFA
 
International organizations combat online sales of counterfeit drugs
Earlier this month, more than 40 countries cooperated in an international week of action to combat the online sale of counterfeit and illegal drugs and to raise awareness of their associated health risks. More...
 
EGA calls for better API quality measures
The European Generic medicines Association (EGA) has made a number of recommendations on how to ensure the quality of medicines in the globalized supply chain; in particular, the EGA spoke about API quality and quality supervision, and how these can be improved by transparent communication between authorities and industry. More...
 
GSK outlines rare diseases strategy
GlaxoSmithKline (GSK) has provided further details concerning its new unit dedicated to rare diseases, which was launched in February. According to the company, the new unit provides the necessary resources to create new medicines or approaches to tackling rare diseases. More...
 
FDA’s discussion meeting on the Prescription Drug User Fee Act
The FDA has posted on its website minutes of the Prescription Drug User Fee Act (PDUFA) reauthorizaton stakeholder meeting, which focused on proposals from the agency and stakeholders for renewing the PDUFA. More...
 
Keep up to date with industry happenings
If you want regular news updates from across the pharma industry then follow us on Twitter!
 
 

Latest blog posts
Pfizer takes biosimilars plunge
Could lawsuits threaten vaccine makers’ livelihood?
No generic substitution in the UK
More blog posts

Latest columns
Europe: a future leader in vaccines
Buyers in short supply
Risk mitigation in high-potency manufacturing
More articles

Upcoming events
Anti-Counterfeiting Americas (8–9 November | USA)
BIO-Europe 2010 (15–17 November | Germany)
EMBALLAGE 2010 (22–25 November | France)
More events

Product Profile
Harmonized Culture Media for MLT

Oxoid and Remel, the world leading microbiology brands of Thermo Fisher Scientific, have introduced a complete portfolio of culture media for the microbiological examination of non sterile pharmaceutical products, as recommended in the Harmonized Microbial Limit Tests chapters in the Ph. Eur, USP and JP (current editions).

Read more...

 
Equipnet

placeholder

Online Auction: Oct 27-28. Bidding starts at 9AM (GMT +1)

Featuring Pharma & Lab Equipment – Assets Formerly of Innothera Lot catalog features equipment from leading manufacturers: Tablet presses, hydraulic homogenisers, filling machines, water tanks, pumps, and more.

Read more...

 

placeholder

Veltek’s new sterile clean room wipes

Veltek debuts new sterile clean room wipes, including the industry’s first sodium hypochlorite and hydrogen peroxide clean room wipes.

Read more...

 

 



Survey
Did your company increase its level of outsourcing for small-molecule development and manufacturing in 2010 compared with 2009?
  Yes, it increased 47%
  No, it stayed the same 41%
  No, it decreased 12%

This week we would like to know...

What is the biggest challenge to implementing cleanroom conditions?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom